Protocol No.: E4512

Title
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fushion Protein
Principal Investigator
Almubarak, Mohammed; Osman, Salman; Shah, Nik
Phase
III
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institutions
Camden Clark Memorial Hospital
Mary Babb Randolph Cancer Center
United Hospital Center
Contacts
Carla Ross, RN
Senior Research Nurse
Phone: +1 304-293-2633
Renee Stevenson, RN
Phone: +1 304-424-2585
Christa Boice, RN
Research Nurse
Phone: +1 304-420-7132

View on ClinicalTrials.gov